Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors

Infectious complications are a major cause of morbidity and mortality in patients with hemato-oncological diseases. Although disease-related immunosuppression represents one factor, aggressive treatment regimens, such as chemotherapy, stem cell transplantation, or antibody treatment, account for a l...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinwald, Mark, Boch, Tobias, Hofmann, Wolf-Karsten, Buchheidt, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841329/
https://www.ncbi.nlm.nih.gov/pubmed/27127405
http://dx.doi.org/10.4137/BMI.S22430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841329/
https://www.ncbi.nlm.nih.gov/pubmed/27127405
http://dx.doi.org/10.4137/BMI.S22430

Ejemplares similares